|
2023
|
Invention
|
Process for the steroselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines and... |
|
2022
|
Invention
|
Process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines an... |
|
2021
|
Invention
|
N-hydroxycarboxamide derivatives useful as inhibitors of mammalian histone deacetylase activity. ... |
|
|
Invention
|
Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use ... |
|
|
Invention
|
New treatments of viral infections. There is provided a compound of formula (I), wherein R1,R2, Q... |
|
|
Invention
|
2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase... |
|
2019
|
Invention
|
Process for the steroselective preparation of chiral 2- [(hetero)arylalkylsulfanyl] pyrimidines a... |
|
|
Invention
|
A process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines ... |
|
2016
|
Invention
|
Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity. A compo... |
|
|
Invention
|
Bisarylsulfonamides useful in the treatment of inflammation and cancer. A compound of formula (I)... |
|
|
Invention
|
2-phenyl-3h-imidazo[4,5-b]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ro... |
|
|
Invention
|
2-phenyl-3h-imidazo[4,5-b]pyridine derivatives useful as inhibitors of mammalian tyrosine kinase ... |
|
2015
|
Invention
|
Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity. A compoun... |
|
2011
|
Invention
|
Antibodies against ror1 and uses thereof. The invention relates to antibodies for inducing cell d... |
|
|
Invention
|
Sulfonamide compounds. A compound of formula (I), wherein A is S, O or a double bond, and L is a ... |
|
|
Invention
|
Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer. A co... |
|
|
G/S
|
Medicines for dental purposes; medicines for human purposes;
medicines for veterinary purposes; ... |
|
2010
|
Invention
|
5,7-disubstituted thiazolo[4,5-d]pyrimidines as chemokine inhibitors. 3CR1 receptor antagonists a... |
|
|
Invention
|
Biological inhibitors of ror1 capable of inducing cell death. The invention relates to antibodies... |
|
2007
|
Invention
|
5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors.... |
